Share · NZX
Should you buy Ryman Healthcare shares?
Ryman Healthcare develops and operates integrated retirement villages and aged-care facilities across New Zealand and Australia, combining independent living with rest-home and hospital-level care. Here is our rating, the honest trade-offs, and how to buy the share from New Zealand.
Key points
- An integrated retirement-village and aged-care operator.
- Operations across New Zealand and Australia.
- Exposure to ageing-population demand.
- Trade-offs: property-cycle and development risk.
01Our review
Ryman Healthcare overview
Ryman Healthcare develops and operates integrated retirement villages and aged-care facilities across New Zealand and Australia, combining independent living with rest-home and hospital-level care. It is listed on the NZX and quoted in New Zealand dollars (NZ$). Our rating follows the HelloBrokers methodology: we weigh the fundamentals, the competitive position and the risks, and we do not publish made-up price targets or a fabricated analyst consensus. Below we set out what we like, the risks to keep in mind, and the practical ways to buy the share from New Zealand through a regulated broker.
Strengths
- Long-term tailwind from an ageing population
- An integrated care and living model
- A large landbank and development pipeline
- A recognised brand in retirement living
Watch-outs
- Earnings are sensitive to the housing cycle
- Development and debt levels carry risk
- Regulatory and care-standard obligations
- Cash flows depend on unit resales
02Snapshot
Ryman Healthcare at a glance
04Our verdict
Should you buy Ryman Healthcare shares?
Retirement-living operator
Ryman Healthcare develops and operates integrated retirement villages and aged-care facilities across New Zealand and Australia, combining independent living with rest-home and hospital-level care. Our view weighs its strengths against its risks, without hype and without invented targets.
This is analysis, not investment advice. The bull case: a long-term tailwind from an ageing population, an integrated care model, and a large development pipeline.
The bear case: earnings are sensitive to the housing cycle, and development and debt levels carry risk. As with any single stock, returns depend on execution and the wider market.
Overall we see Ryman Healthcare as a retirement-living operator. It can suit a diversified, long-term portfolio for investors who understand the risks. As always, we do not publish made-up price targets.
05Get started
How to buy Ryman Healthcare shares
There are two main routes, both of which should go through a regulated broker. A broker comparison is below.
Cash / spot
Buy the cash share through a broker
Open an account with a broker and hold the share directly in New Zealand dollars, with full shareholder rights and any dividends. New Zealand has no general capital-gains tax, so a gain on a personal, long-term investment is generally not taxed when you sell; New Zealand dividends often carry imputation credits. If you buy with the purpose of resale or trade frequently, Inland Revenue (IRD) can treat the profit as taxable income. This is the most direct way to invest for the long term. This is not tax advice.
CFD (leveraged)
Trade it as a CFD (leverage)
Some international brokers offer share CFDs. Leverage amplifies both gains and losses, the cost is the spread plus overnight financing, and you do not own the share. These international brokers are not licensed by the FMA and serve New Zealand clients cross-border. CFDs suit short-term traders who understand the risk; most retail CFD accounts lose money.
For most investors, buying the cash share through a regulated broker and holding for the long term is the most suitable approach. Compare brokers below.
08Where to invest
Where to buy Ryman Healthcare shares
To buy Ryman Healthcare, favour a regulated broker with low fees and good coverage of New Zealand shares. Compare them side by side below.
Compare brokersRyman Healthcare share FAQ
- Through a broker offering access to the New Zealand Exchange (NZX), holding the share in New Zealand dollars. Some international brokers also offer the share as a CFD, but they are not licensed by the FMA and serve New Zealand clients cross-border.
- Yes. Ryman Healthcare trades under the code RYM on the New Zealand Exchange and is quoted in New Zealand dollars (NZ$).
- New Zealand has no general capital-gains tax, so a gain on a personal, long-term investment is generally not taxed when you sell. Dividends often carry imputation credits. If you buy with the purpose of resale or trade frequently, profits can be taxed as income. This is not tax advice.
- No. We do not publish price targets and we refuse to invent figures or a fake consensus. Where a credible, dated analyst view exists we cite the named source; otherwise we say there is none.
Why trust the HelloBrokers view on this share
We are an independent editorial team. Ryman Healthcare does not pay us, and we do not publish invented price targets or a fake analyst consensus. The rating follows our methodology; affiliate links to brokers fund our work but never change the conclusion.
This content is for information only and is not investment advice, a recommendation or an offer. Past performance does not guarantee future results. Investing in shares carries a risk of capital loss; CFDs amplify that risk. Do your own research and consult a qualified professional where needed.